Company / Income Tax per Share
Arcutis Biotherapeutics, Inc. Income Tax per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
$0.00 / $0.04
FY2021-FY2025
Trend
+48.6%
vs FY2024
Sector context
#81 of 201
Health Care
What the data says
At $0.01, Arcutis Biotherapeutics, Inc.'s income tax per share ranks #121 of 201 in the Health Care sector. Improved from $0.04 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2025.
Improved from $0.04 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#121 of 201 in Health CareTop 60% of 201This company $0.01 Sector average $1.35
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 48.6% year-over-year.
- Ranks #81 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2023.
- Lowest income tax per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +48.6% |
| FY2024 | $0.01 | -85.1% |
| FY2023 | $0.04 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026